Stocks
Bristol-Myers (BMY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 6 599 | 14 816 | 20 182 | 19 923 | 19 177 | 17 436 | ||
| Changes by years, y/y, % | +9% | +125% | +36% | -1% | -4% | +25.9% | |||
Bristol-Myers. EBITDA US GAAP, bln rub
Bristol-Myers. EBITDA US GAAP, changes, %
Bristol-Myers. EBITDA US GAAP, sum by quarters, bln rub
Bristol-Myers (BMY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 5 096 | 4 626 | 4 215 | 4 148 | 4 447 | 17 436 | |
| Changes by years, y/y, % | +0% | -14% | -20% | -12% | -13% | |||
| Changes by quarters, q/q, % | +8% | -9% | -9% | -2% | +7% | |||
